Terms: = Lymphoma AND MAF, MGC71685, 4094, ENSG00000178573
67 results:
1. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
[TBL] [Abstract] [Full Text] [Related]
2. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract] [Full Text] [Related]
3. Simultaneous Imaging and Flow-cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-induced Senescent Cancer Cells.
Dovjak E; Mairhofer M; Wöß C; Qi J; Fan DNY; Schmitt CA; Yu Y
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35913198
[TBL] [Abstract] [Full Text] [Related]
4. miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute lymphoblastic leukemia: A case-control study in Tunisia.
Dhiflaoui A; Mahjoub S; Chayeb V; Achour B; Chouchen S; Abdennebi HB; Mahjoub T; Almawi WY
Gene; 2022 Aug; 834():146648. PubMed ID: 35690283
[TBL] [Abstract] [Full Text] [Related]
5. NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness.
Wilkens AB; Fulton EC; Pont MJ; Cole GO; Leung I; Stull SM; Hart MR; Bernstein ID; Furlan SN; Riddell SR
Blood; 2022 Nov; 140(21):2261-2275. PubMed ID: 35605191
[TBL] [Abstract] [Full Text] [Related]
6. Mutation profiling of circulating tumor DNA identifies distinct mutation patterns in non-Hodgkin lymphoma.
Fu H; Shen J; Zhou H; Zhang F; Li H; Ma Z; Huang W; Chen L; Chen Y; Liu T
Eur J Haematol; 2022 Apr; 108(4):298-309. PubMed ID: 34997652
[TBL] [Abstract] [Full Text] [Related]
7. The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma.
Hao S; Lu X; Gong Z; Bassett RL; Hu S; Konoplev SN; Tang G; Li S; Xu J; Khanlari M; Lee HC; Manasanch EE; Weber DM; Orlowski RZ; Medeiros LJ; Lin P
Mod Pathol; 2021 Feb; 34(2):327-335. PubMed ID: 32908255
[TBL] [Abstract] [Full Text] [Related]
8. Different maf translocations confer similar prognosis in newly diagnosed multiple myeloma patients.
Goldman-Mazur S; Jurczyszyn A; Castillo JJ; Waszczuk-Gajda A; Grząśko N; Radocha J; Bittrich M; Kortüm KM; Gozzetti A; Usnarska-Zubkiewicz L; Valls JD; Jayabalan DS; Niesvizky R; Kelman J; Coriu D; Rosiñol L; Szukalski Ł; González-Calle V; Mateos MV; Jamroziak K; Hus I; Avivi I; Cohen Y; Mazur P; Suska A; Chappell A; Madduri D; Chhabra S; Kleman A; Hari P; Delforge M; Robak P; Gentile M; Kozłowska I; Goldberg SL; Czepiel J; Długosz-Danecka M; Silbermann R; Olszewski AJ; Barth P; Mikala G; Chim CS; Vesole DH
Leuk Lymphoma; 2020 Aug; 61(8):1885-1893. PubMed ID: 32306794
[TBL] [Abstract] [Full Text] [Related]
9. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.
Kleinstern G; Yan H; Hildebrandt MAT; Vijai J; Berndt SI; Ghesquières H; McKay J; Wang SS; Nieters A; Ye Y; Monnereau A; Brooks-Wilson AR; Lan Q; Melbye M; Jackson RD; Teras LR; Purdue MP; Vajdic CM; Vermeulen RCH; Giles GG; Cocco PL; Birmann BM; Kraft P; Albanes D; Zeleniuch-Jacquotte A; Crouch S; Zhang Y; Sarangi V; Asmann Y; Offit K; Salles G; Wu X; Smedby KE; Skibola CF; Slager SL; Rothman N; Chanock SJ; Cerhan JR
Hum Mol Genet; 2020 Jan; 29(1):70-79. PubMed ID: 31600786
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Characteristics and Prognosis of maf Deletion in Chinese Patients With Multiple Myeloma.
Wang Y; Li Q; Xing S; Zhang H; Li D
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
[TBL] [Abstract] [Full Text] [Related]
11. HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.
Rushing AW; Rushing B; Hoang K; Sanders SV; Péloponèse JM; Polakowski N; Lemasson I
PLoS Pathog; 2019 Jun; 15(6):e1007922. PubMed ID: 31251786
[TBL] [Abstract] [Full Text] [Related]
12. PD-L1
Pollari M; Brück O; Pellinen T; Vähämurto P; Karjalainen-Lindsberg ML; Mannisto S; Kallioniemi O; Kellokumpu-Lehtinen PL; Mustjoki S; Leivonen SK; Leppä S
Haematologica; 2018 Nov; 103(11):1908-1914. PubMed ID: 30026337
[TBL] [Abstract] [Full Text] [Related]
13. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.
Gutierrez-Camino Á; Umerez M; Martin-Guerrero I; García de Andoin N; Santos B; Sastre A; Echebarria-Barona A; Astigarraga I; Navajas A; Garcia-Orad A
Pharmacogenomics J; 2018 Dec; 18(6):704-712. PubMed ID: 29282364
[TBL] [Abstract] [Full Text] [Related]
14. CMIP is oncogenic in human gastric cancer cells.
Zhang J; Huang J; Wang X; Chen W; Tang Q; Fang M; Qian Y
Mol Med Rep; 2017 Nov; 16(5):7277-7286. PubMed ID: 28944848
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.
Qiu H; Wu H; Chan V; Lau CS; Lu Q
Autoimmunity; 2017 Mar; 50(2):71-81. PubMed ID: 28263097
[TBL] [Abstract] [Full Text] [Related]
16. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
[TBL] [Abstract] [Full Text] [Related]
17. Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS.
Guisier F; Salaün M; Lachkar S; Lamy A; Piton N; Obstoy B; Sabourin JC; Thiberville L
Respirology; 2016 May; 21(4):718-26. PubMed ID: 27099101
[TBL] [Abstract] [Full Text] [Related]
18. Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Hitz F; Zucca E; Pabst T; Fischer N; Cairoli A; Samaras P; Caspar CB; Mach N; Krasniqi F; Schmidt A; Rothermundt C; Enoiu M; Eckhardt K; Berardi Vilei S; Rondeau S; Mey U
Br J Haematol; 2016 Jul; 174(2):255-63. PubMed ID: 27018242
[TBL] [Abstract] [Full Text] [Related]
19. [Features of clinical presentation, pathology and magnetic resonance or computed tomography imaging for ocular lymphoma].
Guo P; Xian J; Chen G; Liang X; Yang B; Wang Z; Yan F
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(11):814-8. PubMed ID: 26080911
[TBL] [Abstract] [Full Text] [Related]
20. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract] [Full Text] [Related]
[Next]
